Biomarker- based identification of high- risk groups for primary hepatocellular carcinoma in chronic hepatitis b patients under the nucleos( t) ide analogue treatment

HEPATOLOGY(2023)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要